Breaking News

SCOTUS to decide on reviewing contentious patent issue; when does value-based drug pricing work best?

 

Pharmalot Ed Silverman

STAT+: A Supreme Court review of a contentious patent issue would change the way pharma claims discoveries

By Ed Silverman

Adobe

“It’s tough to even conceive of a patent case that has a larger economic potential,” said Jacob Sherkow, a University of Illinois professor.

Read More

Opinion: STAT+: Value-based drug pricing: When does it work best?

By Girisha Fernando

Adobe

Value-based drug pricing is not suitable in all situations. Here are four scenarios in which it is clearly appropriate.

Read More

STAT+: George Church startup Manifold Bio raises $40M for 'protein barcoding' technology to improve drug testing

By Ryan Cross — The Boston Globe

Susan Walsh/AP

The firm is designing a system for “barcoding” protein therapies — giving them a unique label so large numbers can be tested at the same.

Read More

Thursday, July 14, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments